日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Adjuvant short-course radiotherapy combined with chemotherapy and a PD-1 inhibitor for resected mucosal melanoma: study protocol for a single-arm, prospective, phase II trial

辅助短程放疗联合化疗和PD-1抑制剂治疗切除后的黏膜黑色素瘤：一项单臂、前瞻性II期试验的研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-114414
Lv, Jiaojie; Shen, Lijun; Jiang, Xuebing; Wu, Ruiyan; Zhou, Shujuan; Zhang, Zhiyuan; Wan, Juefeng; Xia, Lingfang; Liu, Fangqi; Liu, Xin; Chen, Yong; Wang, Yan; Zhang, Zhen; Xu, Yu
PD-1
黑色素瘤
发表日期：2026
文献求助 收藏

m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways.

m6A修饰的circSTX6通过SPI1和IL6/JAK2/STAT3通路作为宫颈癌恶性肿瘤的关键调节因子

期刊:Oncogene
影响因子:7.3
doi:10.1038/s41388-024-03260-5
Han Xiaotian, Xia Lingfang, Wu Yong, Chen Xiaojun, Wu Xiaohua
肿瘤
STAT3
发表日期：2025
文献求助 收藏

Complete response to Mirvetuximab Soravtansine in platinum-resistant recurrent ovarian cancer: a case report

铂耐药复发性卵巢癌患者接受米尔维妥昔单抗索拉夫坦辛治疗后获得完全缓解：病例报告

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-025-01628-z
Wu, Yong; Xia, Lingfang; Song, Chunyan; Chen, Xiaojun; Wu, Xiaohua
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study

zimberelimab (GLS-010) 单药治疗复发或转移性宫颈癌患者的疗效和安全性：一项多中心、单臂 II 期研究

期刊:International Journal of Gynecological Cancer
影响因子:4.7
doi:10.1136/ijgc-2023-004705
Xia, Lingfang; Wang, Jing; Wang, Chunyan; Zhang, Qingming; Zhu, Jianqing; Rao, Qunxian; Cheng, Huijun; Liu, Zheng; Yin, Yongmei; Ai, Xiaohong; Gulina, Kurban; Zheng, Hong; Luo, Xiaoyong; Chang, Baoping; Li, Li; Liu, Haiyan; Li, Yunxia; Lou, Ge; Zhou, Qi; Zhu, Yanling; Xiao, Zemin; Tong, Jiandong; Wang, Ke; Chen, Jie; Wang, Xia; Song, Lijie; Wei, Zhixia; Ye, Yijing; Zhu, Jiman; Wu, Xiaohua
宫颈癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial

术中使用氨甲环酸减少晚期卵巢癌细胞减灭术中的出血：一项随机对照临床试验

期刊:Acta Obstetricia et Gynecologica Scandinavica
影响因子:3.1
doi:10.1111/aogs.14567
Yang, Xijun; Chai, Mao; Xia, Lingfang; He, Zhiyong; Wu, Xiaohua; Zhang, Jun
肿瘤
肿瘤免疫
卵巢癌
细胞生物学
发表日期：2023
文献求助 收藏

A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma

一项针对复发性或转移性宫颈鳞状细胞癌女性患者的卡瑞利珠单抗联合法米替尼的多中心II期临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-35133-4
Xia, Lingfang; Zhou, Qi; Gao, Yunong; Hu, Wenjing; Lou, Ge; Sun, Hong; Zhu, Jianqing; Shu, Jin; Zhou, Xianfeng; Sun, Rong; Wu, Xiaohua
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study

卡瑞利珠单抗联合法米替尼治疗铂类耐药复发性卵巢癌患者的抗肿瘤活性和安全性：一项开放标签、多中心 II 期篮式研究的结果

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003831
Xia, Lingfang; Peng, Jin; Lou, Ge; Pan, Mei; Zhou, Qi; Hu, Wenjing; Shi, Huirong; Wang, Li; Gao, Yunong; Zhu, Jianqing; Zhang, Yu; Sun, Rong; Zhou, Xianfeng; Wang, Quanren; Wu, Xiaohua
肿瘤
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial

安罗替尼治疗中国复发性晚期宫颈癌患者：一项前瞻性单臂、开放标签的II期临床试验

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.720343
Zhu, Jun; Song, Chunyan; Zheng, Zhong; Xia, Lingfang; Chen, Yanqiong; Ke, Guihao; Wu, Xiaohua
宫颈癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia

NPTX2过表达通过IL6-JAK2/STAT3信号通路在缺氧条件下促进上皮性卵巢癌的恶性表型。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.643986
Han, Xiaotian; Lu, Yechen; Li, Xiaoqi; Xia, Lingfang; Wen, Hao; Feng, Zheng; Ju, Xingzhu; Chen, Xiaojun; Wu, Xiaohua
肿瘤
IL6
肿瘤免疫
JAK/STAT
信号转导
卵巢癌
JAK2
STAT3
发表日期：2021
文献求助 收藏

Comparison of different lymph node staging systems in patients with node-positive cervical squamous cell carcinoma following radical surgery

比较不同淋巴结分期系统在根治性手术后淋巴结阳性宫颈鳞状细胞癌患者中的应用

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.48085
Guo, Qinhao; Zhu, Jun; Wu, Yong; Wen, Hao; Xia, Lingfang; Yu, Min; Wang, Simin; Ju, Xingzhu; Wu, Xiaohua
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏